Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus
- 1 May 2011
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 86 (5), 444-456
- https://doi.org/10.4065/mcp.2010.0713
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline
- Forest Laboratories
- National Institutes of Health
- Boehringer Ingelheim
This publication has 124 references indexed in Scilit:
- Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2American Journal of Kidney Diseases, 2010
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseThe New England Journal of Medicine, 2010
- Association of statin use and development of renal dysfunction in type 2 diabetes—The Hong Kong Diabetes RegistryDiabetes Research and Clinical Practice, 2010
- Awareness of Chronic Kidney Disease Among Patients and ProvidersAdvances in Chronic Kidney Disease, 2010
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 DiabetesThe New England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities StudyKidney International, 2000